Document Detail


Nitric oxide in preterm infant with pulmonary hypoplasia.
MedLine Citation:
PMID:  15163873     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Premature infants with hypoplastic lungs may have elevated pulmonary vascular resistance with right to left shunt across ductus arteriosus and/or foramen ovale. Inhaled nitric oxide (NO) being selective pulmonary vasodilator without significant effects on systemic circulation can potentially reverse this shunt. The authors herewith report a case of a premature infant with severe hypoxemic respiratory failure after preterm premature prolonged rupture of membranes leading to oligohydramnios and pulmonary hypoplasia that was treated successfully with NO and describe the neurodevelopmental outcome at 1 year of age.
Authors:
Nandkishor S Kabra; Martin R Kluckow; Jane Powell
Related Documents :
15264703 - Risk factors of mortality in meconium aspiration syndrome: review of 314 cases.
23911593 - The influence of babbling patterns on the processing of speech.
22192263 - Growth and neurodevelopmental outcomes of extremely low birth weight infants: a single ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Indian journal of pediatrics     Volume:  71     ISSN:  0019-5456     ISO Abbreviation:  Indian J Pediatr     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-05-27     Completed Date:  2004-07-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0417442     Medline TA:  Indian J Pediatr     Country:  India    
Other Details:
Languages:  eng     Pagination:  427-9     Citation Subset:  IM    
Affiliation:
Department of Neonatology and University of Sydney, Royal North Shore Hospital, St Leonards, NSW 2065, Australia. nskabra@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Child Development
Echocardiography
Follow-Up Studies
Humans
Infant, Newborn
Infant, Premature*
Male
Nitric Oxide / therapeutic use*
Persistent Fetal Circulation Syndrome / diagnosis*,  therapy*
Pulmonary Gas Exchange
Respiratory Distress Syndrome, Newborn / diagnosis,  therapy*
Respiratory Function Tests
Risk Assessment
Tomography, X-Ray Computed
Treatment Outcome
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Umbilical cord allantoic cysts in a newborn with vacterl association.
Next Document:  Non hodgkin's lymphoma seven years following remission of acute lymphoblastic leukemia.